Janus Henderson Investors

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug

JPMorgan, Barclays, Fifth Third Sued by Investors for Missing ‘Giant Red Flags’ at Tricolor

The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start

Multiliquid, Metalayer Launch Instant Redemption Backstop for RWAs on Solana

Caldera Therapeutics Launches with $112.5M in Total Capital

Software Stocks See Worst Start to Year Since 2022 as AI Disruption Fears Mount

The Week’s 10 Biggest Funding Rounds: Security And Energy Deals Top The List

BlossomHill Therapeutics Inks $84M Series B Extension

Think Bioscience Raises $55M Series A

CesiumAstro to Scale Operations with $470 Million in Equity and Debt Financing

CesiumAstro Raises $470M in Growth Capital, CEO Sabripour Calls It a ‘Scale Moment’

Think Bioscience Secures $55M Series A Funding

Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity

BlossomHill Therapeutics Secures $84M Series B Extension Funding

Parabilis Medicines Secures $305M Series F Funding Led by RA Capital, Fidelity Management, and Janus Henderson

BlossomHill Therapeutics Secures $84M Series B Extension